RTS Life Science has unveiled its revolutionary automated blood fractionation (ABF) system to the US market. This high-throughput blood fractionation system is used to extract the buffy coat (white blood cells) from whole blood samples.
The innovative, upgradable system provides a fully automated solution to blood fractionation and processing. The ABF system is a self-contained unit capable of processing up to 500 samples per day, providing substantial time and labour and cost savings compared with manual fractionation.
The ABF system incorporates Vision System technology that measures the height of each fraction and calculates the volume of each layer following fractionation via centrifugation. The ABF solution also offers significant health and safety benefits by reducing exposure to unscreened blood, and a laboratory information management system (LIMS) interface ensures ease of acquisition and manipulation of data.
www.rtslifescience.com